Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

被引:890
作者
Jonas, S
Bechstein, WO
Steinmüller, T
Herrmann, M
Radke, C
Berg, T
Settmacher, U
Neuhaus, P
机构
[1] Humboldt Univ, Charite Campus Virchow Klinikum, Dept Gen Visceral & Transplantat Surg, D-13353 Berlin, Germany
[2] Humboldt Univ, Charite Campus Virchow Klinikum, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany
[3] Humboldt Univ, Charite Campus Virchow Klinikum, Inst Pathol, D-13353 Berlin, Germany
关键词
D O I
10.1053/jhep.2001.23561
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Selection of patients suffering from hepatocellular carcinoma (HCC) in cirrhosis for liver transplantation follows limits of number and diameter of tumor nodules. It has not been investigated whether there is a correlation of these parameters with vascular invasion. From 1989 to 2000, 1,188 liver transplantations were performed in 1,087 patients, including 120 patients (11%) with an HCC in cirrhosis. Selection criteria were a maximal diameter of up to 5 cm if the tumor appeared to be uninodular or of up to 3 cm in the case of 2 or 3 nodules. The postoperative mortality rate was 1.7%. One-, 5-, and 10-year survival was 90%, 71%, and 60%, respectively. In 940 transplantation patients without an HCC, these rates were 93%, 87%, and 83% (P < .0001). Vascular invasion and histopathologic grading were identified as prognostic parameters by multivariate analysis. In a logistic regression analysis, histopathologic grading and maximal diameter showed a significant correlation with a vascular invasion. Analyzing tumors larger than 5 cm, i.e., tumors not fulfilling the selection criteria as a result of diagnostic inaccuracy or progression thereafter, the rates of vascular invasion were significantly (P < .01) lower in patients suffering from well-differentiated tumors (25%) when compared with moderately and poorly differentiated tumors (100%). Liver transplantation is a safe and effective longterm treatment for small. HCC in cirrhosis. Tumor diameter and number of nodules in correlation with the histopathologic grading were predictive of a vascular invasion only in HCC larger than 5 cm.
引用
收藏
页码:1080 / 1086
页数:7
相关论文
共 34 条
[1]
ROLE OF STAGING LAPAROSCOPY IN THE TREATMENT OF HEPATIC MALIGNANCY [J].
BABINEAU, TJ ;
LEWIS, WD ;
JENKINS, RL ;
BLEDAY, R ;
STEELE, GD ;
FORSE, RA .
AMERICAN JOURNAL OF SURGERY, 1994, 167 (01) :151-155
[2]
INTRAHEPATIC RECURRENCE AFTER RESECTION OF HEPATOCELLULAR-CARCINOMA COMPLICATING CIRRHOSIS [J].
BELGHITI, J ;
PANIS, Y ;
FARGES, O ;
BENHAMOU, JP ;
FEKETE, F .
ANNALS OF SURGERY, 1991, 214 (02) :114-117
[3]
LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].
BISMUTH, H ;
CHICHE, L ;
ADAM, R ;
CASTAING, D ;
DIAMOND, T ;
DENNISON, A .
ANNALS OF SURGERY, 1993, 218 (02) :145-151
[4]
Chapoutot C, 1999, GASTROEN CLIN BIOL, V23, P552
[5]
Gambarin-Gelwan M, 2000, AM J GASTROENTEROL, V95, P1535
[6]
Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma [J].
Jin-no, K ;
Tanimizu, M ;
Hyodo, I ;
Nishikawa, Y ;
Hosokawa, Y ;
Doi, T ;
Endo, H ;
Yamashita, T ;
Okada, Y .
JOURNAL OF GASTROENTEROLOGY, 1998, 33 (03) :376-382
[7]
Treatment of primary hepatocellular carcinoma [J].
Jonas, S ;
Bechstein, WO ;
Kling, N ;
Guckelberger, O ;
Neuhaus, P .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1997, 122 (19) :617-620
[8]
Jonas S, 1997, CANCER, V80, P1141, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1141::AID-CNCR18>3.0.CO
[9]
2-8
[10]
JONAS S, 1995, CLIN TRANSPLANT, V9, P406